Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm with a laboratory testing facility in Puerto Rico, the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. It also offers microbiological and chemical testing services through its lab; and technical trainings/seminars. The company markets its services through industry trade shows, professional conventions, industry publications, and seminars. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Management consulting services
Sub-IndustryN/A
SectorBusiness Services
Current SymbolOTCMKTS:PBSV
Previous Symbol
CUSIPN/A
Phone787-278-2709
Debt
Debt-to-Equity RatioN/A
Current Ratio10.19
Quick Ratio10.19
Price-To-Earnings
Trailing P/E Ratio-19.00
Forward P/E Ratio114.00
P/E GrowthN/A
Sales & Book Value
Annual Sales$15.58 million
Price / Sales1.71
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.90 per share
Price / Book1.27
Profitability
EPS (Most Recent Fiscal Year)($0.06)
Net Income$-1,410,000.00
Net Margins-14.93%
Return on Equity0.49%
Return on Assets0.41%
Miscellaneous
Employees155
Outstanding Shares23,370,000
Market Cap$26.53 million
OptionableNot Optionable
Pharma Bio Serv (OTCMKTS:PBSV) Frequently Asked Questions
What is Pharma Bio Serv's stock symbol?
Pharma Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."
How were Pharma Bio Serv's earnings last quarter?
Pharma Bio Serv Inc (OTCMKTS:PBSV) announced its quarterly earnings data on Friday, September, 14th. The company reported $0.03 EPS for the quarter, beating the Zacks' consensus estimate of $0.01 by $0.02. The firm earned $5.22 million during the quarter, compared to analysts' expectations of $4.29 million. Pharma Bio Serv had a positive return on equity of 0.49% and a negative net margin of 14.93%. View Pharma Bio Serv's Earnings History.
When is Pharma Bio Serv's next earnings date?
Has Pharma Bio Serv been receiving favorable news coverage?
Media stories about PBSV stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Pharma Bio Serv earned a media sentiment score of 1.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days.
Who are some of Pharma Bio Serv's key competitors?
Some companies that are related to Pharma Bio Serv include Gopher Protocol (GOPH), Wilhelmina International (WHLM), China Internet Nationwide Fncl Srvcs (CIFS), Lightbridge (LTBR), TSS (TSSI), DIGIPATH INC/SH SH (DIGP), Cartesian (CRTN), Transatlantic Capital (TACI), HPIL (HPIL), CleanTech Innovations (SIXD), China Xingbang Industry Group (CXGP) and Green Energy Management Services (GRMS).
Who are Pharma Bio Serv's key executives?
Pharma Bio Serv's management team includes the folowing people:
- Ms. Elizabeth Plaza, Founder, Chairman & Sr. Strategic Consultant (Age 54)
- Mr. Victor Sanchez, CEO, Pres & Pres of European Operations (Age 47)
- Mr. Pedro J. Lasanta, CFO, VP of Fin. & Admin. and Sec. (Age 58)
How do I buy shares of Pharma Bio Serv?
Shares of PBSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Pharma Bio Serv's stock price today?
One share of PBSV stock can currently be purchased for approximately $1.14.
How big of a company is Pharma Bio Serv?
Pharma Bio Serv has a market capitalization of $26.53 million and generates $15.58 million in revenue each year. The company earns $-1,410,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis. Pharma Bio Serv employs 155 workers across the globe.
What is Pharma Bio Serv's official website?
How can I contact Pharma Bio Serv?
Pharma Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The company can be reached via phone at 787-278-2709 or via email at [email protected]
MarketBeat Community Rating for Pharma Bio Serv (OTCMKTS PBSV)
MarketBeat's community ratings are surveys of what our community members think about Pharma Bio Serv and other stocks. Vote "Outperform" if you believe PBSV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBSV will underperform the S&P 500 over the long term. You may vote once every thirty days.
